{"organizations": [], "uuid": "aca8ce97efd142fe73745c14258b2f40a4e95fc3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-sobi-says-received-approval-from-h/brief-sobi-says-received-approval-from-health-canada-for-once-daily-dosing-of-orfadin-for-treatment-of-ht-1-idUSFWN1RU0XS", "country": "US", "domain_rank": 408, "title": "BRIEF-SOBI Says Received Approval From Health Canada For Once-Daily Dosing Of Orfadin For Treatment Of HT-1", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-17T15:13:00.000+03:00", "replies_count": 0, "uuid": "aca8ce97efd142fe73745c14258b2f40a4e95fc3"}, "author": "", "url": "https://www.reuters.com/article/brief-sobi-says-received-approval-from-h/brief-sobi-says-received-approval-from-health-canada-for-once-daily-dosing-of-orfadin-for-treatment-of-ht-1-idUSFWN1RU0XS", "ord_in_thread": 0, "title": "BRIEF-SOBI Says Received Approval From Health Canada For Once-Daily Dosing Of Orfadin For Treatment Of HT-1", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-sobi says received approval from health canada for once-daily dosing of orfadin", "sentiment": "negative"}, {"name": "brief-sobi says received approval from health canada for once-daily dosing of orfadi", "sentiment": "negative"}, {"name": "biovitrum ab", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "treatment of ht-1 reuters staff", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 13 PM / Updated 24 minutes ago BRIEF-SOBI Says Received Approval From Health Canada For Once-Daily Dosing Of Orfadin For Treatment Of HT-1 Reuters Staff 1 Min Read \nApril 17 (Reuters) - Swedish Orphan Biovitrum AB (publ) : \n* SOBI SAYS RECEIVED APPROVAL FROM HEALTH CANADA FOR ONCE-DAILY DOSING OF ORFADIN FOR TREATMENT OF HT-1 Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-17T15:13:00.000+03:00", "crawled": "2018-04-17T15:30:53.056+03:00", "highlightTitle": ""}